Tempus Launches Advisory Board with Top U.S. Physicians
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch of...
Tag : Medical Oncology
ENHERTU® EU Approval: First HER2 Therapy for HR+ Metastatic BC
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of...